Literature DB >> 8625300

Microsatellite alterations in bronchial and sputum specimens of lung cancer patients.

M Miozzo1, G Sozzi, K Musso, S Pilotti, M Incarbone, U Pastorino, M A Pierotti.   

Abstract

Early diagnosis of lung cancer based on conventional screening procedures has been unable thus far to decrease lung cancer mortality. We explored the possibility of using microsatellite instability in the detection and screening of early phases of lung carcinogenesis. We studied tumor, histopathologically normal bronchial mucosa, and cytological specimens of 51 lung cancer patients for the presence of clonal variations at microsatellite polymorphisms. Microsatellite alterations were found in tumor, normal bronchial mucosa and cytological specimens of 25 of 51 (49%) of the patients. The detection of microsatellite alterations in histopathologically normal bronchial specimens and cytological clinical samples with minimal atypia suggests a possible application of this genetic marker in early diagnosis of precancerous lesions and lung cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625300

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

Review 1.  Sputum examination for early detection of lung cancer.

Authors:  F B J M Thunnissen
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

2.  Molecular damage in the bronchial epithelium of current and former smokers.

Authors:  I I Wistuba; S Lam; C Behrens; A K Virmani; K M Fong; J LeRiche; J M Samet; S Srivastava; J D Minna; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1997-09-17       Impact factor: 13.506

3.  Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening.

Authors:  A K El-Naggar; L Mao; G Staerkel; M M Coombes; S L Tucker; M A Luna; G L Clayman; S Lippman; H Goepfert
Journal:  J Mol Diagn       Date:  2001-11       Impact factor: 5.568

Review 4.  Benefits and harms of CT screening for lung cancer: a systematic review.

Authors:  Peter B Bach; Joshua N Mirkin; Thomas K Oliver; Christopher G Azzoli; Donald A Berry; Otis W Brawley; Tim Byers; Graham A Colditz; Michael K Gould; James R Jett; Anita L Sabichi; Rebecca Smith-Bindman; Douglas E Wood; Amir Qaseem; Frank C Detterbeck
Journal:  JAMA       Date:  2012-06-13       Impact factor: 56.272

5.  Elevated microsatellite alterations at selected tetra-nucleotide (EMAST) in non-small cell lung cancers--a potential determinant of susceptibility to multiple malignancies.

Authors:  Hiromasa Arai; Koji Okudela; Hisashi Oshiro; Noriko Komitsu; Hideaki Mitsui; Teppei Nishii; Masahiro Tsuboi; Akinori Nozawa; Yasuharu Noishiki; Kenichi Ohashi; Kenji Inui; Munetaka Masuda
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

6.  Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients.

Authors:  Giuseppe Pelosi; Elisabetta Schianchi; Patrizia Dell'orto; Giulia Veronesi; Lorenzo Spaggiari; Felice Pasini; Gabriella Sozzi; Elisabeth Brambilla; Claudia Griso; Giuseppe Viale
Journal:  Virchows Arch       Date:  2005-09-29       Impact factor: 4.064

7.  Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples.

Authors:  Yi-Ching Wang; Yung-Pin Lu; Ruo-Chia Tseng; Ruo-Kai Lin; Jer-Wei Chang; Jung-Ta Chen; Chuen-Ming Shih; Chih-Yi Chen
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  Genetic instability in lung cancer: concurrent analysis of chromosomal, mini- and microsatellite instability and loss of heterozygosity.

Authors:  H Ninomiya; K Nomura; Y Satoh; S Okumura; K Nakagawa; M Fujiwara; E Tsuchiya; Y Ishikawa
Journal:  Br J Cancer       Date:  2006-05-22       Impact factor: 7.640

Review 9.  The molecular basis of lung cancer: molecular abnormalities and therapeutic implications.

Authors:  Pierre P Massion; David P Carbone
Journal:  Respir Res       Date:  2003-10-07

Review 10.  DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update.

Authors:  Paul P Anglim; Todd A Alonzo; Ite A Laird-Offringa
Journal:  Mol Cancer       Date:  2008-10-23       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.